Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in ...

Shares of Stifel Financial were moving higher after it reported fourth-quarter adjusted earnings that beat Wall Street ...

The firm’s CEO cited a “very competitive” recruiting market in 2024, but forecasts a better 2025 as longer-term efforts pay ...

Stifel Nicolaus analyst Ian Gillies maintained a Buy rating on Badger Infrastructure Solutions (BADFF – Research Report) today and set a price ...

In a report released yesterday, Brian Chin from Stifel Nicolaus maintained a Hold rating on Teradyne (TER – Research Report). The company’s ...

Stifel chief executive Ron Kruszewski said surging markets have forced firms to be particularly choosy about which advisors ...

Fintel reports that on January 30, 2025, Stifel upgraded their outlook for Edwards Lifesciences (NYSE:EW) from Hold to Buy. Analyst Price Forecast Suggests 12.29% Upside As of January 28, 2025, the ...

Datadog (NASDAQ: DDOG) stock is losing ground in Wednesday's trading. The company's share price was down 4.9% as of 2:30 p.m.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $125.6, a high estimate of $135.00, and a low estimate of $115.00. This upward trend is evident, ...

Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $89.57 which represents a decrease of $-0.29 or -0.32% from the prior close of $89.86. The stock opened at $90.11 and touched a low of ...

CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced Getinge off the U.S. market in 2015.

The Financial Conduct Authority (FCA) has been warned that some investors would no longer funnel their capital into the investment companies sector if the regulator proceeds with some of its proposals ...